EL7.AI पर प्रदान की गई जानकारी केवल शैक्षिक और सूचनात्मक उद्देश्यों के लिए है और यह वित्तीय सलाह नहीं है।
EL7.AI पर प्रदान की गई जानकारी केवल शैक्षिक और सूचनात्मक उद्देश्यों के लिए है और यह वित्तीय सलाह नहीं है।
NovaBay Pharmaceuticals has officially rebranded as Stablecoin Development Corporation, marking a total strategic shift in its business model. This transformation follows a substantial investment of $134 million aimed at pivoting the company toward the cryptocurrency market. The rebranding signifies a specific shift toward integrating stablecoins into the healthcare sector, targeting the reshaping of payment systems and industry dynamics. As part of this new direction, the company now holds approximately 9% of the total supply of the SKY token, positioning it as a significant stakeholder within the Sky ecosystem, formerly known as MakerDAO. Analysts view this as a notable endorsement of the Sky protocol, although the company's nanocap status may limit its broader market influence. This move reflects a growing trend of traditional firms seeking treasury management and infrastructure opportunities within the decentralized finance (DeFi) space.
इस कंटेंट को एक्सेस करने के लिए मुफ्त साइन अप करें
मुफ्त अकाउंट बनाएं